|
31 |
Bispecific antibodies targeting dual tumor-associated antigens in cancer therapy
Enthalten in Journal of cancer research and clinical oncology 28.9.2020: 1-12
|
|
|
32 |
Target-Mediated Drug Disposition Model for Bispecific Antibodies : Properties, Approximation and Optimal Dosing Strategy
Schropp, Johannes. - Konstanz : KOPS Universität Konstanz, 2019
|
|
|
|
33 |
Engineering Polymer‐Binding Bispecific Antibodies for Enhanced Pretargeted Delivery of Nanoparticles to Mucus‐Covered Epithelium
Enthalten in Angewandte Chemie Bd. 131, 2019, Nr. 17: 5660-5664. 5 S.
|
|
|
|
34 |
Engineering Polymer‐Binding Bispecific Antibodies for Enhanced Pretargeted Delivery of Nanoparticles to Mucus‐Covered Epithelium
Enthalten in Angewandte Chemie / International edition Bd. 58, 2019, Nr. 17: 5604-5608. 5 S.
|
|
|
|
35 |
Modulating Targeting of Poly (ethylene glycol) Particles to Tumor Cells Using Bispecific Antibodies
Enthalten in Advanced healthcare materials Bd. 8, 2019, Nr. 9. 10 S.
|
|
|
|
36 |
T cell-redirecting bispecific antibodies in cancer immunotherapy: recent advances
Enthalten in Journal of cancer research and clinical oncology 23.2.2019: 1-16
|
|
|
|
37 |
Rationale for Combining Bispecific T Cell Activating Antibodies With Checkpoint Blockade for Cancer Therapy
Kobold, Sebastian. - Ludwig-Maximilians-Universität München, 2018
|
|
|
|
38 |
Transcytosis of payloads that are non-covalently complexed to bispecific antibodies across the hCMEC/D3 blood-brain barrier model
Enthalten in Biological chemistry Bd. 399, 2018, Nr. 7: 711-721. 11 S.
|
|
|
|
39 |
Bispecific Antibodies for the Treatment of Acute Myeloid Leukemia
Enthalten in Current hematologic malignancy reports 2.10.2018: 1-9
|
|
|
|
40 |
Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies
Enthalten in BioDrugs 21.8.2018: 1-24
|
|
Administration
